News stories about Express Scripts Holding (NASDAQ:ESRX) have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Express Scripts Holding earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned headlines about the company an impact score of 47.3766189366399 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:
- Express Scripts Holding Company to Present at an Upcoming Conference – Markets Insider (markets.businessinsider.com)
- Express Scripts (ESRX) in Focus: Stock Moves 5.5% Higher – Nasdaq (nasdaq.com)
- Express Scripts Holding Company to Post Q1 2019 Earnings of $1.76 Per Share, William Blair Forecasts (ESRX) (americanbankingnews.com)
Express Scripts Holding (ESRX) opened at 61.35 on Tuesday. The company has a market capitalization of $35.43 billion, a PE ratio of 10.65 and a beta of 0.88. Express Scripts Holding has a one year low of $55.80 and a one year high of $77.50. The firm’s 50 day moving average price is $61.03 and its 200-day moving average price is $61.84.
Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.90. The company had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts Holding had a return on equity of 25.46% and a net margin of 3.64%. Express Scripts Holding’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.74 EPS. Equities analysts forecast that Express Scripts Holding will post $7.00 earnings per share for the current fiscal year.
ESRX has been the topic of several research analyst reports. Robert W. Baird raised their price objective on shares of Express Scripts Holding from $57.00 to $59.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 25th. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. UBS AG downgraded shares of Express Scripts Holding from a “market perform” rating to an “underperform” rating in a research note on Monday, October 9th. Finally, Royal Bank Of Canada set a $66.00 price objective on shares of Express Scripts Holding and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Seven analysts have rated the stock with a sell rating, eleven have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $69.56.
ILLEGAL ACTIVITY WARNING: “Express Scripts Holding (ESRX) Earns News Sentiment Rating of 0.13” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.com-unik.info/2017/10/31/express-scripts-holding-esrx-earns-news-sentiment-rating-of-0-13.html.
In other news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction on Friday, September 8th. The stock was sold at an average price of $63.13, for a total transaction of $36,489.14. Following the sale, the vice president now directly owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Everett Neville sold 1,163 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total value of $71,501.24. Following the sale, the vice president now directly owns 18,232 shares in the company, valued at $1,120,903.36. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,641 shares of company stock worth $357,317. 0.68% of the stock is currently owned by insiders.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
What are top analysts saying about Express Scripts Holding Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Express Scripts Holding Company and related companies.